1	Nicked	Nick	B-NP	VBN	O	5	NMOD	-1
2	{	{	I-NP	NN	B-protein	5	NMOD	-1
3	beta	beta	I-NP	SYM	I-protein	5	NMOD	-1
4	}	}	I-NP	NN	I-protein	5	NMOD	-1
5	2-glycoprotein	2-glycoprotein	I-NP	NN	I-protein	7	SUB	-1
6	I	I	I-NP	CD	I-protein	5	NMOD	-1
7	binds	bind	B-VP	VBZ	O	0	ROOT	15	binds
8	angiostatin	angiostatin	B-NP	NN	O	7	OBJ	-1
9	4.5	4.5	I-NP	CD	O	8	NMOD	-1
10	(	(	O	(	O	14	DEP	-1
11	plasminogen	plasminogen	B-NP	NN	O	13	NMOD	-1
12	kringle	kringle	I-NP	NN	O	13	NMOD	-1
13	1-5	1-5	I-NP	NN	O	14	DEP	-1
14	)	)	O	)	O	8	NMOD	-1
15	and	and	O	CC	O	7	VMOD	-1
16	attenuates	attenuate	B-VP	VBZ	O	7	VMOD	18	attenuates
17	its	its	B-NP	PRP$	O	19	NMOD	-1
18	antiangiogenic	antiangiogenic	I-NP	JJ	O	19	NMOD	3	angiogenic
19	property	property	I-NP	NN	O	16	OBJ	18	property
20	.	.	O	.	O	7	P	-1

1	Angiostatin	Angiostatin	B-NP	NN	B-protein	2	SUB	-1
2	was	be	B-VP	VBD	O	0	ROOT	-1
3	first	first	I-VP	RB	O	2	VMOD	-1
4	discovered	discover	I-VP	VBN	O	2	VC	-1
5	as	as	B-PP	IN	O	4	VMOD	-1
6	a	a	B-NP	DT	O	8	NMOD	-1
7	plasminogen	plasminogen	I-NP	NN	B-DNA	8	NMOD	-1
8	fragment	fragment	I-NP	NN	I-DNA	5	PMOD	-1
9	with	with	B-PP	IN	O	8	NMOD	-1
10	antitumor/antiangiogenic	antitumor/antiangiogenic	B-NP	JJ	O	11	NMOD	3	angiogenic
11	property	property	I-NP	NN	O	9	PMOD	18	property
12	.	.	O	.	O	2	P	-1

1	One	One	B-NP	CD	O	8	SUB	-1
2	of	of	B-PP	IN	O	1	NMOD	-1
3	the	the	B-NP	DT	O	5	NMOD	-1
4	angiostatin	angiostatin	I-NP	NN	B-protein	5	NMOD	-1
5	isoforms	isoform	I-NP	NNS	I-protein	2	PMOD	-1
6	,	,	O	,	O	8	P	-1
7	that	that	B-NP	DT	O	8	SUB	-1
8	is	be	B-VP	VBZ	O	0	ROOT	-1
9	,	,	O	,	O	8	P	-1
10	angiostatin	angiostatin	B-NP	NN	O	31	SUB	-1
11	4.5	4.5	I-NP	CD	O	10	NMOD	-1
12	(	(	O	(	O	14	DEP	-1
13	AS4.5	AS4.5	B-NP	NN	B-protein	14	DEP	-1
14	)	)	O	)	O	10	NMOD	-1
15	,	,	O	,	O	10	P	-1
16	consisting	consist	B-VP	VBG	O	10	NMOD	-1
17	of	of	B-PP	IN	O	16	VMOD	-1
18	plasminogen	plasminogen	B-NP	NN	B-protein	19	NMOD	-1
19	kringle	kringle	I-NP	NN	I-protein	17	PMOD	-1
20	1	1	I-NP	CD	I-protein	19	NMOD	-1
21	to	to	B-PP	TO	O	16	VMOD	-1
22	4	4	B-NP	CD	O	26	NMOD	-1
23	and	and	O	CC	O	26	NMOD	-1
24	a	a	B-NP	DT	O	26	NMOD	-1
25	most	most	I-NP	JJS	O	26	NMOD	-1
26	part	part	I-NP	NN	O	21	PMOD	-1
27	of	of	B-PP	IN	O	26	NMOD	-1
28	kringle	kringle	B-NP	NN	O	27	PMOD	-1
29	5	5	I-NP	CD	O	28	NMOD	-1
30	,	,	O	,	O	10	P	-1
31	is	be	B-VP	VBZ	O	8	VMOD	-1
32	produced	produce	I-VP	VBN	O	31	VC	0
33	by	by	B-PP	IN	O	32	VMOD	-1
34	autoproteolysis	autoproteolysis	B-NP	NN	O	33	PMOD	0
35	and	and	O	CC	O	32	DEP	-1
36	present	present	B-ADJP	JJ	O	32	VMOD	0
37	in	in	B-PP	IN	O	36	AMOD	-1
38	human	human	B-NP	JJ	B-cell_type	39	NMOD	-1
39	plasma	plasma	I-NP	NN	I-cell_type	37	PMOD	-1
40	.	.	O	.	O	8	P	-1

1	beta2-glycoprotein	beta2-glycoprotein	B-NP	NN	O	6	SUB	-1
2	I	I	I-NP	CD	O	1	NMOD	-1
3	(	(	O	(	O	5	DEP	-1
4	beta2GPI	beta2GPI	B-NP	NN	O	5	DEP	-1
5	)	)	O	)	O	1	NMOD	-1
6	is	be	B-VP	VBZ	O	0	ROOT	-1
7	proteolytically	proteolytically	I-VP	RB	O	6	VMOD	-1
8	cleaved	cleave	I-VP	VBN	O	6	VC	17	cleaved
9	by	by	B-PP	IN	O	8	VMOD	-1
10	plasmin	plasmin	B-NP	NN	O	9	PMOD	-1
11	in	in	B-PP	IN	O	8	VMOD	-1
12	its	its	B-NP	PRP$	O	14	NMOD	-1
13	domain	domain	I-NP	NN	O	14	NMOD	-1
14	V	V	I-NP	NN	O	11	PMOD	-1
15	(	(	O	(	O	18	DEP	-1
16	nicked	nicked	B-NP	JJ	B-protein	17	NMOD	-1
17	beta2GPI	beta2GPI	I-NP	NN	I-protein	18	DEP	-1
18	)	)	O	)	O	14	NMOD	-1
19	,	,	O	,	O	6	P	-1
20	resulting	result	B-VP	VBG	O	6	VMOD	17	resulting
21	in	in	B-PP	IN	O	20	VMOD	-1
22	binding	bind	B-VP	VBG	O	21	PMOD	15	binding
23	to	to	B-PP	TO	O	22	VMOD	-1
24	plasminogen	plasminogen	B-NP	NN	B-protein	23	PMOD	-1
25	.	.	O	.	O	6	P	-1

1	Antiangiogenic	Antiangiogenic	B-NP	JJ	O	2	NMOD	3	angiogenic
2	properties	property	I-NP	NNS	O	3	SUB	18	properties
3	have	have	B-VP	VBP	O	0	ROOT	-1
4	been	be	I-VP	VBN	O	3	VC	-1
5	recently	recently	I-VP	RB	O	6	VMOD	-1
6	reported	report	I-VP	VBN	O	4	VC	-1
7	in	in	B-PP	IN	O	6	VMOD	-1
8	nicked	nicked	B-NP	JJ	B-cell_line	9	NMOD	-1
9	beta2GPI	beta2GPI	I-NP	NN	I-cell_line	7	PMOD	-1
10	as	as	B-CONJP	RB	O	7	PMOD	-1
11	well	well	I-CONJP	RB	O	10	DEP	-1
12	as	as	I-CONJP	IN	O	10	DEP	-1
13	in	in	B-PP	IN	O	7	PMOD	-1
14	intact	intact	B-NP	JJ	O	15	NMOD	-1
15	beta2GPI	beta2GPI	I-NP	NN	O	13	PMOD	-1
16	at	at	B-PP	IN	O	6	VMOD	-1
17	higher	high	B-NP	JJR	O	18	NMOD	-1
18	concentrations	concentration	I-NP	NNS	O	16	PMOD	-1
19	.	.	O	.	O	3	P	-1

1	In	In	B-PP	IN	O	7	VMOD	-1
2	the	the	B-NP	DT	O	4	NMOD	-1
3	present	present	I-NP	JJ	O	4	NMOD	0
4	study	study	I-NP	NN	O	1	PMOD	-1
5	,	,	O	,	O	7	P	-1
6	we	we	B-NP	PRP	O	7	SUB	-1
7	found	find	B-VP	VBD	O	0	ROOT	0
8	significant	significant	B-NP	JJ	O	9	NMOD	-1
9	binding	binding	I-NP	NN	O	7	OBJ	15	binding
10	of	of	B-PP	IN	O	9	NMOD	-1
11	nicked	nicked	B-NP	JJ	O	12	NMOD	-1
12	beta2GPI	beta2GPI	I-NP	NN	O	10	PMOD	-1
13	to	to	B-PP	TO	O	9	NMOD	-1
14	AS4.5	AS4.5	B-NP	NN	B-protein	27	NMOD	-1
15	(	(	O	(	O	26	DEP	-1
16	K	K	B-NP	NN	O	23	NMOD	-1
17	(	(	O	(	O	19	DEP	-1
18	D	D	B-NP	NN	O	19	DEP	-1
19	)	)	O	)	O	16	NMOD	-1
20	=	=	B-VP	SYM	O	23	VMOD	-1
21	3.27	3.27	B-NP	CD	O	23	AMOD	-1
22	x	x	O	SYM	O	23	AMOD	-1
23	10	10	B-NP	CD	O	26	DEP	-1
24	(	(	O	(	O	26	DEP	-1
25	6	6	B-NP	CD	O	26	DEP	-1
26	)	)	O	)	O	14	NMOD	-1
27	M	M	B-NP	NN	O	13	PMOD	-1
28	(	(	O	(	O	30	DEP	-1
29	-1	-1	B-NP	CD	O	30	DEP	-1
30	)	)	O	)	O	27	NMOD	-1
31	)	)	O	)	O	27	NMOD	-1
32	.	.	O	.	O	7	P	-1

1	Via	Via	B-NP	NNP	O	3	NMOD	0
2	this	this	B-NP	DT	O	3	NMOD	-1
3	binding	binding	I-NP	NN	O	7	SUB	15	binding
4	,	,	O	,	O	7	P	-1
5	nicked	nicked	B-NP	JJ	O	6	NMOD	-1
6	beta2GPI	beta2GPI	I-NP	NN	O	7	SUB	-1
7	attenuates	attenuate	B-VP	VBZ	O	0	ROOT	18	attenuates
8	the	the	B-NP	DT	O	10	NMOD	-1
9	antiangiogenic	antiangiogenic	I-NP	JJ	O	10	NMOD	3	angiogenic
10	functions	function	I-NP	NNS	O	7	OBJ	18	functions
11	of	of	B-PP	IN	O	10	NMOD	-1
12	AS4.5	AS4.5	B-NP	NN	B-protein	11	PMOD	-1
13	in	in	B-PP	IN	O	7	VMOD	-1
14	the	the	B-NP	DT	O	15	NMOD	-1
15	proliferation	proliferation	I-NP	NN	O	13	PMOD	1	proliferation
16	of	of	B-PP	IN	O	15	NMOD	-1
17	arterial/venous	arterial/venous	B-NP	JJ	B-cell_type	19	NMOD	-1
18	endothelial	endothelial	I-NP	JJ	I-cell_type	19	NMOD	-1
19	cells	cell	I-NP	NNS	I-cell_type	16	PMOD	-1
20	,	,	O	,	O	7	P	-1
21	in	in	B-PP	IN	O	7	VMOD	-1
22	the	the	B-NP	DT	O	25	NMOD	-1
23	extracellular	extracellular	I-NP	JJ	O	25	NMOD	-1
24	matrix	matrix	I-NP	NN	O	25	NMOD	-1
25	invasion	invasion	I-NP	NN	O	29	NMOD	14	invasion
26	and	and	O	CC	O	29	NMOD	-1
27	the	the	B-NP	DT	O	29	NMOD	-1
28	tube	tube	I-NP	NN	O	29	NMOD	-1
29	formation	formation	I-NP	NN	O	21	PMOD	2	formation
30	of	of	B-PP	IN	O	29	NMOD	-1
31	venous	venous	B-NP	JJ	B-cell_type	33	NMOD	-1
32	endothelial	endothelial	I-NP	JJ	I-cell_type	33	NMOD	-1
33	cells	cell	I-NP	NNS	I-cell_type	30	PMOD	-1
34	,	,	O	,	O	38	P	-1
35	and	and	O	CC	O	38	NMOD	-1
36	in	in	B-NP	FW	O	37	AMOD	-1
37	vivo	vivo	I-NP	FW	O	38	NMOD	-1
38	angiogenesis	angiogenesis	I-NP	NN	O	7	VMOD	3	angiogenesis
39	.	.	O	.	O	7	P	-1

1	In	In	B-PP	IN	O	6	VMOD	-1
2	contrast	contrast	B-NP	NN	O	1	PMOD	-1
3	,	,	O	,	O	6	P	-1
4	intact	intact	B-NP	JJ	O	5	NMOD	-1
5	beta2GPI	beta2GPI	I-NP	NN	O	6	SUB	-1
6	does	do	B-VP	VBZ	O	0	ROOT	-1
7	not	not	I-VP	RB	O	6	VMOD	-1
8	bind	bind	I-VP	VB	O	6	VC	15	bind
9	to	to	B-PP	TO	O	8	VMOD	-1
10	AS4.5	AS4.5	B-NP	NN	B-protein	9	PMOD	-1
11	or	or	O	CC	O	8	VMOD	-1
12	inhibit	inhibit	B-VP	VB	O	8	VMOD	18	inhibit
13	its	its	B-NP	PRP$	O	15	NMOD	-1
14	antiangiogenic	antiangiogenic	I-NP	JJ	O	15	NMOD	3	angiogenic
15	activity	activity	I-NP	NN	O	12	OBJ	18	activity
16	.	.	O	.	O	6	P	-1

1	Thus	Thus	B-ADVP	RB	O	5	VMOD	-1
2	,	,	O	,	O	5	P	-1
3	nicked	nicked	B-NP	JJ	B-protein	4	NMOD	-1
4	beta2GPI	beta2GPI	I-NP	NN	I-protein	5	SUB	-1
5	exerts	exert	B-VP	VBZ	O	24	VMOD	-1
6	dual	dual	B-NP	JJ	O	7	NMOD	-1
7	effects	effect	I-NP	NNS	O	5	OBJ	0
8	on	on	B-PP	IN	O	5	VMOD	-1
9	angiogenesis	angiogenesis	B-NP	NN	O	8	PMOD	3	angiogenesis
10	,	,	O	,	O	5	P	-1
11	that	that	B-NP	DT	O	5	OBJ	-1
12	is	be	B-VP	VBZ	O	16	VMOD	-1
13	,	,	O	,	O	16	P	-1
14	nicked	nicked	B-NP	JJ	O	15	NMOD	-1
15	beta2GPI	beta2GPI	I-NP	NN	O	16	SUB	-1
16	promotes	promote	B-VP	VBZ	O	11	NMOD	17	promotes
17	angiogenesis	angiogenesis	B-NP	NN	O	16	OBJ	3	angiogenesis
18	in	in	B-PP	IN	O	17	NMOD	-1
19	the	the	B-NP	DT	O	20	NMOD	-1
20	presence	presence	I-NP	NN	O	18	PMOD	0
21	of	of	B-PP	IN	O	20	NMOD	-1
22	AS4.5	AS4.5	B-NP	NN	B-protein	21	PMOD	-1
23	,	,	O	,	O	24	P	-1
24	whereas	whereas	O	IN	O	0	ROOT	-1
25	nicked	nicked	B-NP	JJ	B-protein	26	NMOD	-1
26	beta2GPI	beta2GPI	I-NP	NN	I-protein	27	SUB	-1
27	inhibits	inhibit	B-VP	VBZ	O	24	VMOD	18	inhibits
28	angiogenesis	angiogenesis	B-NP	NN	O	27	OBJ	3	angiogenesis
29	at	at	B-PP	IN	O	27	VMOD	-1
30	concentrations	concentration	B-NP	NNS	O	29	PMOD	-1
31	high	high	B-ADJP	JJ	O	30	NMOD	-1
32	enough	enough	I-ADJP	RB	O	31	AMOD	-1
33	to	to	B-VP	TO	O	34	VMOD	-1
34	neutralize	neutralize	I-VP	VB	O	31	AMOD	0
35	AS4.5	AS4.5	B-NP	NN	B-protein	34	OBJ	-1
36	.	.	O	.	O	24	P	-1

1	Our	Our	B-NP	PRP$	O	2	NMOD	-1
2	data	datum	I-NP	NNS	O	3	SUB	-1
3	suggest	suggest	B-VP	VBP	O	0	ROOT	-1
4	that	that	B-SBAR	IN	O	3	VMOD	-1
5	plasmin-nicked	plasmin-nicked	B-NP	JJ	O	6	NMOD	-1
6	beta2GPI	beta2GPI	I-NP	NN	O	7	SUB	-1
7	promotes	promote	B-VP	VBZ	O	4	SBAR	16	promotes
8	angiogenesis	angiogenesis	B-NP	NN	O	7	OBJ	3	angiogenesis
9	by	by	B-PP	IN	O	7	VMOD	-1
10	interacting	interact	B-VP	VBG	O	9	PMOD	15	interacting
11	with	with	B-PP	IN	O	10	VMOD	-1
12	plasmin-generated	plasmin-generated	B-NP	JJ	O	13	NMOD	-1
13	AS4.5	AS4.5	I-NP	NN	O	11	PMOD	-1
14	in	in	B-PP	IN	O	13	NMOD	-1
15	sites	site	B-NP	NNS	O	14	PMOD	-1
16	of	of	B-PP	IN	O	15	NMOD	-1
17	increased	increase	B-NP	VBN	O	18	NMOD	0
18	fibrinolysis	fibrinolysis	I-NP	NN	O	16	PMOD	-1
19	such	such	B-PP	JJ	O	20	PMOD	-1
20	as	as	I-PP	IN	O	15	NMOD	-1
21	thrombus	thrombus	B-NP	NN	O	20	PMOD	-1
22	.	.	O	.	O	3	P	-1

